Miller Fisher Syndrome Following Vaccination against SARS-CoV-2

被引：15

作者：

Yamakawa, Makoto ^{[1
]}

Nakahara, Keiichi ^{[1
]}

Nakanishi, Toshihito ^{[2
]}

Nomura, Toshiya ^{[1
]}

Ueda, Mitsuharu ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan

[2] Kumamoto Kinoh Hosp, Dept Neurol, Kumamoto, Japan

来源：

INTERNAL MEDICINE | 2022年 / 61卷 / 07期

关键词：

Miller Fisher syndrome; vaccine; COVID-19; SARS-CoV-2; adverse event;

D O I：

10.2169/internalmedicine.8851-21

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

After BNT162b2 messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccination, a 30-year-old man developed bilateral lateral gaze palsy, diplopia, absent tendon reflexes, and ataxic gait. Se-rum anti-GQ1b and anti-GT1a immunoglobulin G (IgG) antibodies were strongly positive. Based on those findings, he was diagnosed with Miller Fisher syndrome (MFS). Intravenous immunoglobulin therapy was administered, and his symptoms fully recovered within approximately 3 months. To the best of our knowl-edge, this is the first report to describe the development of MFS after COVID-19 mRNA vaccination.

引用

页码：1067 / 1069

页数：3

共 14 条

[1] SERUM IGG ANTIBODY TO GANGLIOSIDE GQ1B IS A POSSIBLE MARKER OF MILLER FISHER SYNDROME
CHIBA, A
KUSUNOKI, S
SHIMIZU, T
KANAZAWA, I
[J]. ANNALS OF NEUROLOGY, 1992, 31 (06) : 677 - 679
[2] Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Fantini, Jacques
Di Scala, Coralie
Chahinian, Henri
Yahi, Nouara
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)
[3] UNUSUAL VARIANT OF ACUTE IDIOPATHIC POLYNEURITIS (SYNDROME OF OPHTHALMOPLEGIA, ATAXIA AND AREFLEXIA)
FISHER, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1956, 255 (02) : 57 - 65
[4] Guillain-Barr acute accent e syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine
Garcia-Grimshaw, Miguel
Michel-Chavez, Anaclara
Vera-Zertuche, Juan Mauricio
Galnares-Olalde, Javier Andres
Hernandez-Vanegas, Laura E.
Figueroa-Cucurachi, Melissa
Paredes-Ceballos, Orlando
Reyes-Teran, Gustavo
Carbajal-Sandoval, Guillermo
Ceballos-Liceaga, Santa Elizabeth
Arauz, Antonio
Valdes-Ferrer, Sergio Ivan
[J]. CLINICAL IMMUNOLOGY, 2021, 230
[5] Guillain-Barre syndrome following influenza vaccination
Haber, P
DeStefano, F
Angulo, FJ
Iskander, J
Shadomy, SV
Weintraub, E
Chen, RT
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (20): : 2478 - 2481
[6] Guillain-Barre Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response
Hughes, Dempsey L.
Brunn, Jenna A.
Jacobs, Jansen
Todd, Peter K.
Askari, Fredrick K.
Fontana, Robert J.
[J]. LIVER TRANSPLANTATION, 2022, 28 (01) : 134 - 137
[7] Surveillance for Adverse Events After COVID-19 mRNA Vaccination
Klein, Nicola P.
Lewis, Ned
Goddard, Kristin
Fireman, Bruce
Zerbo, Ousseny
Hanson, Kayla E.
Donahue, James G.
Kharbanda, Elyse O.
Naleway, Allison
Nelson, Jennifer Clark
Xu, Stan
Yih, W. Katherine
Glanz, Jason M.
Williams, Joshua T. B.
Hambidge, Simon J.
Lewin, Bruno J.
Shimabukuro, Tom T.
DeStefano, Frank
Weintraub, Eric S.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14): : 1390 - 1399
[8] Clinical features and prognosis of Miller Fisher syndrome
Mori, M
Kuwabara, S
Fukutake, T
Yuki, N
Hattori, T
[J]. NEUROLOGY, 2001, 56 (08) : 1104 - 1106
[9] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS
NARANJO, CA
BUSTO, U
SELLERS, EM
SANDOR, P
RUIZ, I
ROBERTS, EA
JANECEK, E
DOMECQ, C
GREENBLATT, DJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 239 - 245
[10] Guillain-Barre syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association
Ogbebor, Osakpolor
Seth, Harshit
Min, Zaw
Bhanot, Nitin
[J]. IDCASES, 2021, 24

← 1 2 →